PEDIATRICS Vol. 104 No. 6 December 1999, pp. 1300-1311

A Comparison of Morning-Only and Morning/Late Afternoon Adderall to Morning-Only, Twice-Daily, and Three Times-Daily Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder

Received Mar 3, 1999; accepted Jun 4, 1999.

William E. Pelham^*, Elizabeth M. Gnagy^*, Andrea M. Chronis^*, Lisa Burrows-MacLean^*, Gregory A. Fabiano^*, Adia N. Onyango^*, David L. Meichenbaum^*, Andy Williams^*, Helen R. Aronoff, and Randi L. Steiner^*

From the Departments of ^* Psychology and  Psychiatry, State University of New York at Buffalo, Buffalo, New York.

Objective.  1) To compare standard twice-daily methylphenidate (MPH) dosing with a single morning dose of MPH and of Adderall during a typical school-day time period, and 2) to conduct a dose-response study of the effects of a late-afternoon (3:30 PM) dose of MPH and Adderall on evening behavior and side effects.

Design.  Within-subject, placebo-controlled, crossover design.

Setting.  Intensive summer treatment program with a comprehensive behavioral approach.

Study Participants.  Twenty-one children with attention-deficit/hyperactivity disorder (19 boys and 2 girls), between the ages of 6 and 12 years.

Interventions.  Children received, in random order with daily crossovers, each of the following conditions: 1) placebo, 2) 0.3 mg/kg of MPH received 3 times, 3) 0.3 mg/kg of MPH received twice (7:30 AM and 11:30 AM) with 0.15 mg/kg received at 3:30 PM, 4) 0.3 mg/kg of MPH received once in the morning only, 5) 0.3 mg/kg of Adderall received at 7:30 AM and at 3:30 PM, 6) 0.3 mg/kg of Adderall once in the morning with 0.15 mg/kg received at 3:30 PM, 7) 0.3 mg/kg of Adderall received in the morning only.

Outcome Measures.  Daily rates of behaviors in social and academic settings, and standardized ratings from counselors and teachers, were assessed for the hours between 8:00 AM and 3:30 PM (a typical school-day). Relative sizes of the medication effects were compared hourly between first daily ingestion (7:30 AM) and 4:45 PM to assess the time course of the 2 drugs. Effects of the 3:30 PM doses on functioning in the evenings at home were evaluated using parent ratings of behavioral and side effects.

Results.  A single morning dose of Adderall produced equivalent behavioral effects to those of MPH received twice-daily and behavioral effects of that single morning dose lasted throughout the school-day period. One morning dose of MPH was less effective than either 2 daily doses of MPH or 1 dose of Adderall, and seemed to wear off in the early to mid-afternoon. For some children a single morning dose of MPH maintained their behavior for an entire school day in the context of the summer treatment program. On parent ratings of evening behavior, 0.3 mg/kg of MPH at 3:30 PM was superior to 0.15 mg/kg at 3:30 PM, but there was no difference between the 2 doses of Adderall. Compared with placebo at 3:30 PM, only the 0.3 mg/kg dose of MPH caused significant improvement in parent ratings. In placebo versus Adderall comparisons, all doses, even the condition that consisted of Adderall in the morning and placebo at 3:30 PM, produced a significant change in evening behavior.

Conclusions.  The results show that, at least in the context of an intensive behavioral intervention, a single morning dose of Adderall had behavioral effects throughout an entire school day period that were equivalent to standard twice-daily MPH dosing. These results indicate that Adderall may be used as a long-acting stimulant for children for whom midday dosing is a problem. Further study including dose-response comparisons, effects in regular school settings, and direct comparisons with comparable doses of MPH and d-amphetamine will help to clarify the time course and relative advantages of Adderall.  Key words:  attention deficit/hyperactivity disorder, stimulants, Adderall, methylphenidate.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. G. Winterstein, T. Gerhard, J. Shuster, and A. Saidi Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD Pediatrics, July 1, 2009; 124(1): e75 - e80. [Abstract] [Full Text] [PDF]

				S. V. Faraone, J. Biederman, and B. Zimmerman An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD J Atten Disord, September 1, 2007; 11(2): 157 - 166. [Abstract] [PDF]

				S. B. Wigal and T. L. Wigal The laboratory school protocol: its origin, use, and new applications. J Atten Disord, August 1, 2006; 10(1): 92 - 111. [Abstract] [PDF]

				J. Biederman, F. A. Lopez, S. W. Boellner, and M. C. Chandler A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/Hyperactivity Disorder Pediatrics, August 1, 2002; 110(2): 258 - 266. [Abstract] [Full Text] [PDF]

				W. E. Pelham, E. M. Gnagy, L. Burrows-Maclean, A. Williams, G. A. Fabiano, S. M. Morrisey, A. M. Chronis, G. L. Forehand, C. A. Nguyen, M. T. Hoffman, et al. Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings Pediatrics, June 1, 2001; 107 (6): e105 - e105. [Abstract] [Full Text] [PDF]

				E. H. Wender Managing Stimulant Medication for Attention-deficit/Hyperactivity Disorder Pediatr. Rev., June 1, 2001; 22(6): 183 - 190. [Full Text] [PDF]

				P. A. Ahmann, F. W. Theye, R. Berg, A. J. Linquist, A. J. Van Erem, and L. R. Campbell Placebo-Controlled Evaluation of Amphetamine Mixture{---}Dextroamphetamine Salts and Amphetamine Salts (Adderall): Efficacy Rate and Side Effects Pediatrics, January 1, 2001; 107(1): 10e - 10. [Abstract] [Full Text]

				Adderall or Methylphenidate for Children with ADHD? Journal Watch Psychiatry, February 1, 2000; 2000(201): 16 - 16. [Full Text]

				Adderall or Ritalin for Children with ADHD? Journal Watch (General), December 28, 1999; 1999(1228): 4 - 4. [Full Text]

eLetters: